
Tetrahedron p. 4035 - 4050 (1997)
Update date:2022-08-03
Topics:
Claridge, Timothy D.W.
Long, James M.
Brown, John M.
Hibbs, David
Hursthouse, Michael B.
The synthesis of the title compound is described, involving 2-lithiation and phosphinylation of the coupled heterocycle in the final step. Attempts to resolve the phosphine by previously described methods led to its immediate racemisation, also observed more slowly in the PdCl2 complex, for which the X-ray structure is described. The phosphinamine formed a cationic pd(1,3-diphenylallyl) complex with high diastereoselectivity. By analysis of the solution stucture using NMR techniques, in comparison with the X-ray structure, some inferences about the mechanism of allylic alkylation with related heterotopic ligands can be drawn.
View MoreNanjing HuiBaiShi Biotechnology Co.,Ltd.
Contact:+86 (25)58745219
Address:No.606 Ningliu Road,LiuHe District.
Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd
Contact:86-27-52341789
Address:Room 1518 B suite, optical valley time square, No 111 Guanshan Road, Hongshan District,Wuhan,Hubei Province,China.
NanJing KaiHeng Chemical CO., LTD.
Contact:+86-25-85768391
Address:RM.1704, D, WANDA PLAZA, NO.110, MIDDLE JIANGDONG ROAD, NANJING, CHINA
Yueyang Hudex Pharmaceuticals Ltd.
Contact:0730-8748800
Address:Wujiang Bridge,Yueyang Economy & Technology Development Zone
website:http://www.simagchem.com
Contact:+86-592-2680277
Address:21/F Hualong Office Building,No.6 Hubin East Road, Xiamen,China
Doi:10.1021/jf980440y
(1998)Doi:10.1016/j.saa.2013.12.017
(2014)Doi:10.1016/j.tetlet.2014.01.144
(2014)Doi:10.1016/S0277-5387(00)83459-2
(1994)Doi:10.1016/j.tet.2018.11.018
(2019)Doi:10.1021/jm00041a017
(1994)